Order Article Reprints

Christen M, Kaderli D, Ratknic M, de Angelis AD, Aebi PS, Porret N, Tchinda J, Baran N, Rim W, Tanner PJ, et al. Real-World Retrospective Report on the Efficacy, Tolerability, and Molecular Responses to Ropeginterferon-α2b in Patients with Myeloproliferative Neoplasms. Journal of Clinical Medicine. 2026; 15(1):128. https://doi.org/10.3390/jcm15010128

Christen, Matthias, Domenic Kaderli, Milos Ratknic, Adrián Dante de Angelis, Philipp Stefan Aebi, Naomi Porret, Joëlle Tchinda, Natalia Baran, Wuddri Rim, Pascale Julia Tanner, and et al. 2026. "Real-World Retrospective Report on the Efficacy, Tolerability, and Molecular Responses to Ropeginterferon-α2b in Patients with Myeloproliferative Neoplasms" Journal of Clinical Medicine 15, no. 1: 128. https://doi.org/10.3390/jcm15010128

Christen, M., Kaderli, D., Ratknic, M., de Angelis, A. D., Aebi, P. S., Porret, N., Tchinda, J., Baran, N., Rim, W., Tanner, P. J., Mathes, S., Angelillo-Scherrer, A., Rovó, A., & Meyer, S. C. (2026). Real-World Retrospective Report on the Efficacy, Tolerability, and Molecular Responses to Ropeginterferon-α2b in Patients with Myeloproliferative Neoplasms. Journal of Clinical Medicine, 15(1), 128. https://doi.org/10.3390/jcm15010128